期刊文献+

褪黑素载药纳米粒的优化设计及研制 被引量:4

Preparation and design of nanoparticles loaded with melatonin
下载PDF
导出
摘要 目的 :探讨采用复合乳液 -溶剂挥发法制备褪黑素载药纳米粒的最佳工艺条件。方法 :以聚乳酸、壳聚糖可降解生物材料为载体 ,明胶为分散剂 ,span - 80和tween - 80混合液为微乳液 ,根据微粒的表面形态、粒径大小分布、包封率、载药量选择最佳工艺条件 ,制备褪黑素载药纳米粒。结果与结论 :原子力显微镜下可见纳米粒表面圆滑 ,分布均匀。正交设计效应曲线图直观分析和方差分析结果显示 ,搅拌速度、溶剂挥发温度、聚乳酸与褪黑素投药比、壳聚糖浓度是影响制备工艺的主要因素。在 30℃ ,10 0 0r/min搅拌速度 ,搅拌时间 4 5min ,m(褪黑素 ) :m(聚乳酸 )为 1:5 ,V(Tween - 80 ) :V(Span - 80 )为 5 :1,壳聚糖质量浓度为 1%条件下 ,可制备成平均粒径为 4 5 .84nm ,包封率为 38.33% ,载药量为 8.35 Aim: To select the best method to prepare nanoparticles loaded with melatonin by co-emulsification-solvent evaporation technique. Methods: Based on the poly-lactic acid and chitosan as biodegradable carrier, glutin was used as dispersion, microemulsion was preparated by mixing Span-80 with Tween-80. According to shapes, sizes of particles, dispersion, rate of drug loading, entrapment efficiency, and character of nanoarticles, the best technique to prepare nanoparticles loaded with melatonin was selected. Results and Conclusion: AFM(atomic force microscope probe) showed glaze of nanoparticles and uniformity of dispersion. Effective curve and analysis of variance showed that stirring speed, reaction temperature, ratio of poly-lactic acid and melatonin, concentration of chitosan were the main factors. MT-NPs could be prepared according to optimum factors described below as reaction temperature at 30 ℃, stirring speed at 1 000 r/min, stirring time for 45 min, ratio of MT and PLA to 1:5, ratio of Tween-80 and Span-80 to 5:1, concentration of CS 1% with the average particle sizes 45.84 nm, entrapment efficiency of 38.33%, and drug loading of 8.35%.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2004年第6期1041-1045,共5页 Journal of Zhengzhou University(Medical Sciences)
关键词 褪黑素 聚乳酸 壳聚糖 纳米粒 微乳液 melatonin(MT) poly-lactic acid(PLA) chitosan(CS) nanoparticles(NPs) microemulsion
  • 相关文献

参考文献11

二级参考文献67

共引文献100

同被引文献57

  • 1费广鹤,刘荣玉,张志红,周江宁.支气管哮喘患者唾液褪黑素和皮质醇水平及其与病情的关系[J].中华结核和呼吸杂志,2003,26(11):679-682. 被引量:9
  • 2吴士文,杨光,金民,郭军红,于生元.脑梗死患者血清褪黑素节律改变与卒中后日间过度倦睡[J].中风与神经疾病杂志,2004,21(6):538-540. 被引量:20
  • 3李玉宝.纳米药物控释系统[A].见:李玉宝主编.纳米生物医药材料[C].北京:化学工业出版社,2004.80.
  • 4Hans ML, Lowman AM. Biodegradable nanoparticles for drug delivery and targeting. Curr Opin Solid State Mater Sci,2002,6:319.
  • 5Soppimath KS, Aminabhavi TM, Kulkarni AR, et al. Biodegradable polymeric nanoparticles as drug deliver" devices.J Control Release,2001,70(1-2) :1.
  • 6Tian YM,Zhang GY,Dai YR.Melatonin rejuvenates degenerated thymus and redresses peripheral immune functions in aged mice[J].Immunol Lett,2003,88(2):101-140.
  • 7Arias J,Melean E,Valero N,et al.Effect of melatonin on lymphocyte protiferation and production of interleukin-2(IL-2) and interleukin-1 beta(IL-1 beta) in mice splenocytes[J].Imest Clin,2003,44(1):40-50.
  • 8Wei W,Shen YX,Dai M,et al.Effects and mechanisms of melatonin on immune responses in mice of different months[J].Acta Pharmacol Sin,2003,24(7):719-723.
  • 9Huang YS,Jiang JW,Wu GC,et al.Effect of melatonin and electroacupuncture on NK cells activity,interleukin-2 production and POMC-derived peptides in traumatic rats[J].Acupunct Electrother Res,2002,27(2):95-105.
  • 10Currier NL,Sun LZY,Miller SC,et al.Exogenous melatonin:quantitative enhancement in vivo of cells mediating non-specific immunity[J].J Neuroimmunol,2000,104(2):101-108.

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部